Authors: Tadokoro, Koh | Morihara, Ryuta | Ohta, Yasuyuki | Hishikawa, Nozomi | Kawano, Satoko | Sasaki, Ryo | Matsumoto, Namiko | Nomura, Emi | Nakano, Yumiko | Takahashi, Yoshiaki | Takemoto, Mami | Yamashita, Toru | Ueno, Setsuko | Wakutani, Yosuke | Takao, Yoshiki | Morimoto, Nobutoshi | Kutoku, Yumiko | Sunada, Yoshihide | Taomoto, Katsushi | Manabe, Yasuhiro | Deguchi, Kentaro | Higashi, Yasuto | Inufusa, Haruhiko | You, Fukka | Yoshikawa, Toshikazu | von Greiffenclau, Markus Matuschka | Abe, Koji
Article Type:
Research Article
Abstract:
Oxidative stress is part of the entire pathological process that underlies the development of Alzheimer’s disease (AD), including the mild cognitive impairment (MCI) stage. Twendee X (TwX) is a supplement containing a strong antioxidative mix of eight antioxidants, which has been shown to have a clinical and therapeutic benefit in AD model mice. Here, we conducted a multicenter, randomized, double-blind, and placebo-controlled prospective interventional study to evaluate the efficacy of TwX in mitigating MCI. The primary outcomes were differences in Mini-Mental State Examination (MMSE) and Hasegawa Dementia Scale-revised (HDS-R) scores between baseline and six months for placebo and TwX groups.
…Seventy-eight subjects with MCI were randomized into placebo (n = 37) and TwX (n = 41) groups. MMSE scores at six months differed significantly between the TwX and placebo groups (p = 0.018), and HDS-R scores for the TwX group exhibited a significant improvement at six months relative to baseline (p = 0.025). The TwX group did not show any change in affective or activities of daily living scores at six months. The present study indicates that strong antioxidative supplement TwX is clinical beneficial for cognitive function in subjects with MCI.
Show more
Keywords: Dementia, dietary supplement, mild cognitive impairment, oxidative stress, randomized controlled trial
DOI: 10.3233/JAD-190644
Citation: Journal of Alzheimer's Disease,
vol. 71, no. 3, pp. 1063-1069, 2019
Price: EUR 27.50
